How it works:
Cagrilintide is an amylin analogue (amylin mimetic) that acts on receptors in the brain and gastrointestinal tract. It reduces appetite, slows gastric emptying, promotes weight loss, and improves glycaemic control.
Recommended for:
- Researchers studying obesity and diabetes therapies
- Clinical centres conducting trials in endocrinology
- Specialists investigating metabolic disorders
Studies and research:
- Clinical trials demonstrated significant weight loss in obese patients treated with Cagrilintide.
- When combined with GLP-1 receptor agonists, it enhanced glycaemic control.
- Studied as a novel therapeutic option for type 2 diabetes and metabolic syndrome.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)
